---
figid: PMC11004261__fcell-12-1353860-g005
figtitle: 'Revolutionizing pediatric neuroblastoma treatment: unraveling new molecular
  targets for precision interventions'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11004261
filename: fcell-12-1353860-g005.jpg
figlink: /pmc/articles/PMC11004261/figure/F5/
number: F5
caption: 'The signaling pathway of ROR1/2 in pediatric NB progression. The initiation
  of ROR1 signaling commences with the binding of a non-canonical WNT ligand, which
  triggers the formation of a complex involving either ROR1 and ROR2 or ROR1 and a
  FZD receptor. It triggers the phosphorylation of ROR1 by various kinases, inhibiting
  anti-apoptotic pathways and activating pathways such as MAPK/ERK, PI3K/AKT, and
  NF-κB. These pathways prompt cytoskeletal changes, enhance tumor cell migration,
  and promote gene expression linked to cell proliferation, survival, EMT, and therapy
  resistance. ROR1, Receptor tyrosine kinase-like orphan receptor 1; WNT, Wingless/Integrated;
  FZD, Frizzled receptors; RAS, Rat sarcoma; RAF, Rapidly Accelerated Fibrosarcoma;
  MEK, mitogen-activated extracellular signal-regulated kinase; ERK, extracellular
  signal-regulated kinases; mTOR: mammalian target of rapamycin; PI3K, phosphoinositide
  3-kinase; Akt, Ak strain transforming; EMT, Epithelial-mesenchymal transitions;
  ASK1, Apoptosis signal-regulating kinase 1; MKK3/6, MAP kinase 3/6; STAT3, Signal
  transducer and activator of transcription 3.'
papertitle: 'Revolutionizing pediatric neuroblastoma treatment: unraveling new molecular
  targets for precision interventions.'
reftext: Min Zheng, et al. Front Cell Dev Biol. 2024;12:1353860.
year: '2024'
doi: 10.3389/fcell.2024.1353860
journal_title: Frontiers in Cell and Developmental Biology
journal_nlm_ta: Front Cell Dev Biol
publisher_name: Frontiers Media S.A.
keywords: neuroblastoma | molecular targets | immunotherapy | precision interventions
  | preclinical studies
automl_pathway: 0.953804
figid_alias: PMC11004261__F5
figtype: Figure
redirect_from: /figures/PMC11004261__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11004261__fcell-12-1353860-g005.html
  '@type': Dataset
  description: 'The signaling pathway of ROR1/2 in pediatric NB progression. The initiation
    of ROR1 signaling commences with the binding of a non-canonical WNT ligand, which
    triggers the formation of a complex involving either ROR1 and ROR2 or ROR1 and
    a FZD receptor. It triggers the phosphorylation of ROR1 by various kinases, inhibiting
    anti-apoptotic pathways and activating pathways such as MAPK/ERK, PI3K/AKT, and
    NF-κB. These pathways prompt cytoskeletal changes, enhance tumor cell migration,
    and promote gene expression linked to cell proliferation, survival, EMT, and therapy
    resistance. ROR1, Receptor tyrosine kinase-like orphan receptor 1; WNT, Wingless/Integrated;
    FZD, Frizzled receptors; RAS, Rat sarcoma; RAF, Rapidly Accelerated Fibrosarcoma;
    MEK, mitogen-activated extracellular signal-regulated kinase; ERK, extracellular
    signal-regulated kinases; mTOR: mammalian target of rapamycin; PI3K, phosphoinositide
    3-kinase; Akt, Ak strain transforming; EMT, Epithelial-mesenchymal transitions;
    ASK1, Apoptosis signal-regulating kinase 1; MKK3/6, MAP kinase 3/6; STAT3, Signal
    transducer and activator of transcription 3.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - STAT3
  - CRX
  - RPGR
  - WNT5B
  - WNT5A
  - WNT11
  - SRC
  - FGR
  - FYN
  - YES1
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - MTOR
  - MAP2K3
  - MAP2K6
  - CRK
  - MAPK14
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - CCNE1
  - CCND1
  - CDK4
  - TAFAZZIN
  - WWTR1
  - FOS
  - FOSB
  - FOSL1
  - FOSL2
  - JUN
  - JUNB
  - JUND
  - BCL2
  - BCL2L1
  - CASP3
  - ITK
  - SLC22A3
  - YAP1
  - CRD
  - MEK
  - Nucleus
---
